Published in Cancer Weekly, September 11th, 2001
"Infection of tumor cells by herpes simplex virus 1 (HSV-1) results in cell destruction and production of progeny virion in a process referred to as viral oncolysis," explained H. Nakamura and colleagues, Harvard University, Massachusetts General Hospital, Boston, Massachusetts. They proposed that oncolysis may be enhanced with suicide gene therapy, but the trick would be to find a gene and prodrug combination that would not affect viral...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly